Stoke Therapeutics (STOK) Other Non Operating Income (2019 - 2026)
Stoke Therapeutics (STOK) posted Other Non Operating Income of $308,000 for Q2 2026, compared with $28,000 a year earlier.
Powered by 
Analysis
Stoke Therapeutics (STOK) Other Non Operating Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other Non Operating Income at Stoke Therapeutics was $219,000, down 23.2% year-over-year; for FY2025, it came in at -$51,000.
- In prior years, Stoke Therapeutics' Other Non Operating Income was -$247,000 in FY2024, $166,000 in FY2023 (-0.6%), $167,000 in FY2022 (+19.3%) and $140,000 in FY2021 (+38.6%).
- The Q2 2026 figure stands as the highest quarterly Other Non Operating Income in data going back to Q2 2019.
- On a year-over-year basis, Other Non Operating Income increased in 1 of the last four quarters, with growth averaging 58.4%.
- The strongest year-over-year quarter for Other Non Operating Income in the past five years was Q4 2024, with growth of 390.2%; the weakest was Q3 2025, with a decline of 89.3%.
- According to Business Quant data, Other Non Operating Income for the three prior quarters was $18,000 (Q1 2026), -$110,000 (Q4 2025) and $3,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Stoke Therapeutics | 1.60 Bn | 429.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 308,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -110,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | -48,000.00 |
| Mar 31, 2024 | -428,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
API Access
Stoke Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();